Two Lots of Ratio-Prednisolone Eye Drops Recalled

Ottawa, ON: Health Canada is advising consumers that Ratiopharm Inc., of Mirabel, Quebec, has voluntarily recalled all units from Lot HF26 and Lot HF27 of the prescription drug Ratio-Prednisolone Ophthalmic Solution (DIN 00700401) in 1.0% strength because some bottles may contain particles that could lead to increased eye irritation. Health Canada will continue to monitor the effectiveness of this recall.

Ratio-Prednisolone (1.0%) eye drops are taken for inflammation of the eye. Patients using the affected lots may notice visible particles in the bottle and may have difficulty squeezing out the product due to a blockage by particles. Potential adverse events may include a gritty feeling in the eye or general eye irritation and could lead to corneal abrasion. To date, only one adverse reaction of blurry vision has been reported in Canada that is associated with the use of this product.

Legal Help

If you or a loved one has suffered illness or an adverse health event resulting from the use of this product, lease click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Published on Mar-23-10